|Articles|December 1, 2005

Conference on Hepatitis A prevention stresses the importance of preventing viral hepatitis at all stages of life

S

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Contemporary Pediatrics

The future of PMOS care: GLP-1 therapy and weight-loss caution

AAP expands RSV immunization recommendations for high-risk children

AAP recommends 2026-2027 COVID-19 vaccine for all infants 6 to 23 months and at-risk older children

HPV vaccination coverage stalls for fourth straight year as rural-urban gap persists, CDC finds

The unharmonious 2026 child and adolescent immunization schedule